WEBINAR: Planning for Success - Designing a Comprehensive Composition of Matter Patent Strategy Using Solid Forms
When medicinal chemists create a new chemical entity, the solid form is rarely optimized because the initial focus is on activity and not drug delivery. As the NCE program matures, however, manufacturing, supply, and drug delivery become increasingly important. These other aspects of drug development present opportunities for patenting. This webinar will discuss some of those opportunities and how resulting IP can be used to protect and leverage the final drug product estate.
Attendees will:- Learn about fundamental IP principles relevant to pharmaceutical development
- Become more familiar with IP pharmaceutical terminology
- Develop an understanding of what a solid form is, how it is protected, and how it can be used to protect pharmaceutical product portfolios
Presenter:
Eyal Barash, JD, Founder, Barash Law
Eyal founded Barash Law LLC in 2009 to be a “roving” in-house General and IP counsel to early and mid-stage start-ups primarily coming out of the Purdue Research Park in West Lafayette, Indiana. He advises or has advised more than 20 start-up companies from Purdue alone and taken them through multiple stages of development including in-licenses, out-licenses, public offerings, private sales and public exits. In 2018, one of Eyal’s clients, Endocyte, Inc. was sold to Novartis for over $2B. Eyal was chief patent counsel to Endocyte for almost 10 years.
Eyal is also a prolific speaker and lecturer, giving presentations primarily in life science IP throughout the globe. He has a particular interest in drug repositioning and repurposing and lectures on this topic frequently. Eyal’s current clients have a global footprint and are in the pharmaceutical, medical device, energy, defense, and agriculture sectors.
Date: October 14, 2020 (REPLAY)
Time: 1:00 pm Central Daylight
Brought to you by Arrowhead Publishers, the organizers of the:
Registrant agrees to receive a post-webinar email sales follow-up from the sponsor of this webinar.